ACHV (Achieve Life Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena

ACHV (Achieve Life Sciences, Inc.) Stock Financials & Earnings | Market Cap Arena

ACHVAchieve Life Sciences, Inc.

Mkt Cap$233M

Healthcare·Biotechnology·🇨🇦 Canada·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$52M

EPS (TTM)-$1.38

Free Cash Flow (TTM)-$41M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$11M
Q1 23	$0	$0	-$9M
Q2 23	$0	$0	-$8M
Q3 23	$0	-$100K	-$7M
Q4 23	$0	$0	-$4M
Q1 24	$0	$0	-$6M
Q2 24	$0	$0	-$8M
Q3 24	$0	$0	-$12M
Q4 24	$0	$0	-$12M
Q1 25	$0	$0	-$13M
Q2 25	$0	$0	-$13M
Q3 25	$0	-$54K	-$15M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$11M	-$11M
Q1 23	-$8M	-$8M
Q2 23	-$7M	-$7M
Q3 23	-$5M	-$5M
Q4 23	-$4M	-$4M
Q1 24	-$5M	-$5M
Q2 24	-$5M	-$5M
Q3 24	-$10M	-$10M
Q4 24	-$9M	-$9M
Q1 25	-$11M	-$11M
Q2 25	-$9M	-$9M
Q3 25	-$11M	-$11M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$15K
Q4 23	$6K
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+52.7%
Q1 23	—	+18.7%
Q2 23	—	-23.4%
Q3 23	—	-48.0%
Q4 23	—	-59.6%
Q1 24	—	-30.3%
Q2 24	—	+9.3%
Q3 24	—	+89.7%
Q4 24	—	+177.9%
Q1 25	—	+115.5%
Q2 25	—	+49.0%
Q3 25	—	+17.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$778K	—
Q1 23	$1M	—
Q2 23	$1M	—
Q3 23	$1M	—
Q4 23	-$10K	—
Q1 24	$1M	—
Q2 24	$1M	—
Q3 24	$1M	—
Q4 24	$1M	—
Q1 25	$2M	—
Q2 25	$3M	—
Q3 25	$2M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$9M	$2M	—
Q1 23	$6M	$3M	—
Q2 23	$5M	$3M	—
Q3 23	$4M	—	$3M
Q4 23	$2M	$2M	—
Q1 24	$3M	$3M	—
Q2 24	$5M	$3M	—
Q3 24	$8M	$5M	—
Q4 24	$7M	$5M	—
Q1 25	$7M	$6M	—
Q2 25	$7M	$6M	—
Q3 25	$5M	$9M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$25M	$0	$25M
Q1 23	$17M	$0	$17M
Q2 23	$25M	$0	$25M
Q3 23	$20M	$0	$20M
Q4 23	$16M	$0	$16M
Q1 24	$66M	$0	$66M
Q2 24	$15M	$47M	$61M
Q3 24	$10M	$33M	$43M
Q4 24	$13M	$22M	$34M
Q1 25	$13M	$10M	$23M
Q2 25	$52M	$4M	$55M
Q3 25	$32M	$16M	$48M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	14M	+39.6%
Q1 23	18M	+32.4%
Q2 23	19M	+6.3%
Q3 23	21M	+10.9%
Q4 23	21M	+0.2%
Q1 24	25M	+18.3%
Q2 24	34M	+37.0%
Q3 24	34M	+0.1%
Q4 24	35M	+0.5%
Q1 25	35M	+0.5%
Q2 25	35M	+0.0%
Q3 25	35M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$729K	41
FY 14	$775K	35
FY 15	$443K	41
FY 16	$298K	17
FY 17	$0	13
FY 18	$0	13
FY 19	$0	14
FY 20	$0	13
FY 21	$0	16
FY 22	$0	20
FY 23	$0	22
FY 24	$0	25